Pemafibrate improves dyslipidemia in patients with type 2 diabetes
Pemafibrate, a novel selective PPARa modulator, significantly improved insulin resistance and lipid abnormalities in patients with type 2 diabetes with high triglyceride levels and was well tolerated, according to a study published January... read more
Patients with monoclonal gammopathy need follow up to detect multiple myeloma
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer even after three decades of stable disease, says a study published January 17, 2017... read more
Slower walking speed in the elderly may be explained by loss of muscle strength and mass
A new research published January 17, 2018 in The Journal of Physiology has shown that elderly people walk at a slower speed and tire more quickly because of loss of strength and mass in leg muscles.... read more
WHO position statement on use of delamanid for MDR-TB
The WHO Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB). WHO is advising national TB programmes and other stakeholders to only add delamanid to a longer MDR-TB regimen... read more
Botulinum toxin may help people with bruxism
In a study reported January 17, 2018 in Neurology, people with bruxism who received onabotulinum toxin-A injections in their chewing muscles were more likely to improve on assessments of their teeth grinding and clenching symptoms than people... read more
Home visits may be an effective intervention in reducing obesity in at-risk children
According to a new study published online January 16, 2018 in Pediatrics, nurse and social worker home visits could be an effective intervention in reducing obesity rates in at-risk populations; 78.3% children who received home visits were at a healthy weight at two years of age compared to 63.6%.... read more